American Head & Neck Society

Advancing Education, Research, and Quality of Care for the Head and Neck oncology patient.

  • About
    • Mission Statement and Purpose
    • Divisions & Services of the Society
      • Education
        • Scientific Program/Resident Courses
        • Surgical Videos
        • Journal Club
        • Journals
        • Global Outreach
        • Awards
          • Margaret F. Butler Award
      • Diversity, Equity and Inclusion Division
      • Patient Care
        • Cancer Survivorship
          • Patient Education on Post-Treatment Care
          • Interviews with Cancer Survivors
        • Cancer Prevention
          • SLIDE DECK: HPV-Related Oropharyngeal Cancer
        • Guidelines/Position Statements
        • Find-A-Physician
      • Research
        • Grant Information
        • Clinical Trial
        • Tissue Banks
      • Administrative Division
        • AHNS Process for Evaluating Projects Requiring Funding
    • Leadership
    • History
      • Society Background
      • AHNS History Interviews
      • Past Presidents
      • In Memory
    • AHNS Newsletter
    • Professionalism & Ethics
    • AHNS Policies and Procedures (P&P) Manual
    • AHNS Foundation
    • AHNS Bylaws
    • AHNS Staff
    • AHNS News and Announcements
    • COVID-19 Bulletin Board
  • Heads Up!
  • Post a Job
  • Meetings
    • AHNS Virtual Education Series
      • TORS Webinar Series
    • AHNS Meetings Info
    • AHNS Call For Abstracts
    • Past Meetings
    • Related Meetings
  • For Patients
  • For Trainees
    • Fellowship Curriculum for FY2024-2025
      • For Current AHNS Fellows
      • Certificate of Completion Request
    • Accredited Fellowships
      • Directory of Fellowships
      • AHNS Fellowship Match
      • Fellowship Curriculum
      • Fellowship Graduates
      • For Program Directors
    • AHNS Surgical Videos
    • Fellows’ Virtual Tumor Boards
    • Cutaneous Cancer
  • Sections
    • Endocrine Surgery
    • Skull Base Surgery Section
    • Reconstructive Head & Neck Surgery
      • Head and Neck Reconstruction- Information for Patients
    • Mucosal Malignancy Section
      • Mucosal Malignancy Section Patient Information
    • Salivary Gland Section
      • Salivary Gland Section Patient Education Handout: Parotidectomy
    • Cutaneous Cancer
  • Find-A-Physician
  • Member Central
    • Join AHNS
    • Find-A-Physician
    • Mailing List Order
  • Login
    • Password Reset
  • Donate

Oral Cavity Cancer: Professional Version

Additional considerations for treatment

For early oral cavity cancers, the depth of invasion correlates with the risk of nodal metastasis. [4]. Therefore, superficially invasive cancers may require only resection of the primary only. A meta-analysis evaluating published literature suggests that lesions over 4mm depth of invasion may benefit from staging neck dissection. [5]

The NCCN guidelines suggest that primary radiation therapy can be used in select circumstances for the treatment of early stage oral cavity cancers. While radiation alone for oral cavity cancers can be an effective modality for treatment of these cancers, the reported literature is not robust and primary surgical management is recommended. The toxicity of radiation to the oral cavity is substantial, and generally considered greater than that of surgery.

Very advanced oral cavity cancers that involve most of the tongue present a unique challenge. Although these cancers can be curable with surgery and adjuvant therapy, total glossectomy is a high morbidity procedure with permanent effects on speech and swallowing. In some cases, a concomitant total laryngectomy may also be needed because of intractable aspiration. Non-surgical treatment with chemotherapy and radiation therapy may be the best overall treatment strategy for these patients. In these cases, an individualized treatment plan with a multidisciplinary team is needed. The risks/benefits of surgical and non-surgical modalities need to be weighed against patient expectations and quality of life. These cases are some of the most challenging oral cancer cases to manage. 

Followup

Routine follow up is crucial helpful for surveillance of possible recurrence or the development of a second primary malignancy. In general, follow up is recommended every 3-4 months for the first 2 years, and every 6 months until five years, and then yearly after 5 years. While most recurrences usually occur in the first two years, [6], five years is generally accepted as the milestone to define cure.

The follow up visit usually includes a complete interval history and complete head and neck exam. Endoscopic evaluation is recommended to evaluate hard to visualize areas like the posterior tongue, as well as to survey for potential second primary cancers. The risk of a second primary head and neck cancer in patients with a history of tobacco use is roughly 2% per year (need ref), hence the need for continued close observation.

For survival by stage, please see the section on epidemiology.

In addition to survival quality of life (QOL) following treatment is also important. Post treatment dysphagia can be severe and potentially permanent. Taste is often affected, especially following the use of radiation. Significant swallowing difficulties with poor control of secretions may result in aspiration, which may necessitate tracheostomy. Gastrostomy tube feeding may be needed in the short term until swallowing improves. After neck dissection, temporary shoulder dysfunction may proceed to permanent disability without therapy. These functional concerns are addressed in the post-treatment period by speech language pathologists, nutritionists, or occupational/physical therapy, coordinated by the head and neck surgeon. The AHNS strongly supports a multidisciplinary team approach to the evaluation and followup of head and neck cancer patients.


 

» Click Here If You Have Questions or Comments

Share:

  • Facebook
  • Twitter
  • LinkedIn
Pages: 1 2 3 4 5 6 7 8 9 10 11 12

News and Announcements

  • AHNS YMCP Episode 11 – Melina Windon, MD, Janice Farlow, MD, Eric Gantwerker, MD May 8, 2025
  • Artificial Intelligence in Management of H&N Cancer: New Horizons Presented April 28, 2025
  • A conversation with Dr. Uppaluri: Neoadjuvant Therapy for Advanced H&N Mucosal April 25, 2025
  • The End of April Head and Neck Cancer Awareness Month Approaches! April 23, 2025
  • April is National CBD Awareness Month! April 21, 2025

AHNS Meetings and Events

AHNS 2025 Annual Meeting
Held during the Combined Otolaryngology Spring Meetings (COSM)

May 14-18, 2025
Hyatt Regency New Orleans
New Orleans, Louisiana

learn more...

Contact Us

AHNS, 11300 W. Olympic Blvd, Suite 600
Los Angeles, CA 90064
ph: (310) 437-0559 / fx: (310) 437-0585
[email protected]

Welcome to the AHNS Virtual Repository of Scientific Research

Sections

  • Virtual Repository of Scientific Resources
  • Cell Lines Browse and Search
  • Omics Browse and Search
  • Patient Derived Xenografts Browse and Search
  • Plasmids Browse and Search
  • Pre-Clinical Models Browse and Search
  • Transferable Expertise Browse and Search
  • Transgenic Mice Browse and Search

© 2002–2025 American Head and Neck Society · Privacy and Return Policy
· Managed by BSC Management, Inc